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Available online 5 June 2013Three new and five known sesquiterpene lactones were isolated from the roots of Laser trilobum
(L.) Borkh. Chemical identity of the known compounds and structural analysis of the new ones
were determined by HR MS and NMR spectroscopy. The two new sesquiterpene lactones:
2-acetoxytrilobolide and 2-hydroxy-10-deacetyltrilobolide belong to the guaianolide type, and
the third one, eudeslaserolide, to the biogenetically related eudesmanolide type. Both types,
together with their biogenetic precursor of germacranolide type (laserolide) are present in
L. trilobum, as well as in the related Laserpitium species. Purposefully selected set of these native
sesquiterpene lactones was tested for specific immunobiological properties. The obtained results
demonstrate that trilobolide and its acetoxy analog are strong activators of cytokine secretion. On
the contrary, the other L. trilobum and Laserpitium siler constituents are only very mild activators,
or even inhibitors of the cytokine and nitric oxide production.
© 2013 The Authors. Published by Elsevier B.V. Open access under CC BY-NC-ND license.Keywords:
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Laser trilobum (L.) Borkh. becameone of the preferred species
for investigation during our previous systematic study [1–3]
concerning chemotaxonomic significance of sesquiterpene lac-
tones serving as phytochemical markers for detecting phyloge-
netic relationships in Apiaceae and Asteraceae families [4,5].
High content of trilobolide (1), the major sesquiterpene lactone
in the roots of L. trilobum, allowednot only the full determination
of its structure [2,3], but also testing and assessing its cytotoxic
properties in human and animalmalignant cells [6]. Later, it was
investigated together with other sesquiterpene lactones also forstry and Biochemistry,
rague, Czech Republic.
tha).
r B.V. Open access under CC BYits insect deterrent activity [7] expecting chemoecological
implication [8], recently upgraded in [9].
Trilobolide (1) is the substantial and characteristic sesqui-
terpene lactone constituent of guaianolide type isolated from
L. trilobum [1–4]. Its chemical structure is closely related to the
extensively studied thapsigargin (3) from Thapsia garganica L.
[10,11], which iswell-known as a potent and selective inhibitor
of sarco-endoplasmic reticulum Ca2+-ATPase (SERCA) leading
to rapid elevation of intracellular calcium [11–15]. It has
already been shown that thapsigargin interferes also with
production of nitric oxide (NO) [16]. Since the biosynthesis of
NO is under tight control of cytokines, we extended our
investigation to the possible effects of thapsigargin (3) and its
closely related structural analog trilobolide (1) on secretion of
interferon-γ (IFN-γ) and production of NO [17].
Close structural relation between the trilobolide (1) and
thapsigargin (3), as it is shown in Fig. 1, together with the
taxonomic relation between their plant sources L. trilobum (L.)
Borkh. and T. garganica L. (both belonging to the family
Apiaceae) indicate also remarkable similarity in their biological-NC-ND license.
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Note: Ac = acetyl, Ang = angelyl (see substituent at C-3 of trilobolide
 (1)) and Mebut = methylbutyryl (see subst. at C-8 of 1 or 4)
Fig. 1. Chemical structures of trilobolide (1) and related constituents of L. trilobum compared with the thapsigargin (4).
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T. garganica represents important medicinal plant utilized for
medical treatment since ancient times, and thus became a
matter of intensive phytochemical and pharmacological study
[11,18]. In contrary, L. trilobum (syn. Siler trilobum) is a common
perennial herbaceous mountain plant (known as gladich),
although, with fruits occasionally used (e.g. in Turkey) as a
spice or condiment [19] with significant antimicrobial effect on
a series of pathogen bacteria [20] endangering food- or feed-
stuffs. Its German name Rosskümmel might indicate a similar
sense. Nevertheless, it remained less attractive for a proper
phytotherapeutic study.
Our recent interest in trilobolide (1) and structurally
related sesquiterpene lactones has been reopened and encour-
aged by discovering their remarkable immunobiological proper-
ties [16–18]. The significant immunostimulatory activity of
trilobolide (1) led us to submit appropriate patent application[21]. The invention relates to the use of trilobolide (1) for
stimulation of the immune system, particularly for stimulation of
the IFN-γ secretion, and to the possible use of this activity in
therapy. It relates also to methods of the trilobolide (1)
separation from roots, or even more reasonably, from seeds of
gladich (L. trilobum), and alternatively also from two additional
plant sources, laserworts: (Laserpitium siler L.) or (Laserpitium
archangelicaWulf. in Jacq.) [22].
Plant sources of various sesquiterpene lactones are
common in nature [23] and have long ago been studied in
our laboratory as plant representatives of the family Apiaceae
(Umbelliferae) [1–5,22]. For the present pharmacology study
L. trilobum was selected as a source for its high content of
trilobolide (1), and for containing a whole range of other
biogenetically and thus also structurally related minor
sesquiterpene lactones [3,4]. Originally, these substances
were isolated from the roots of plants growing wild in their
159J. Harmatha et al. / Fitoterapia 89 (2013) 157–166natural localities. Collecting roots, however, appeared for this
perennial plant rather destructive. Moreover, almost all
localities belong at present to protected natural territories.
This led us to resolve the situation by the plant cultivation in
suitable field conditions, aiming to raise sufficient production
of L. trilobum for its harvesting, processing and suggested use
[21]. We verified that L. trilobum contains trilobolide (1) not
only in roots, but also in other organs, particularly in seeds
[21]. This allows collecting seeds (or whole umbels) from the
umbelliformed mature inflorescence of the plant, avoiding in
that way its unwanted destruction. We present in this paper,
however, results obtained by processing our stored material
(extracts, fractions, separated compounds) from the root
supplies gained in our previous, at that time unrestricted
collections [3]. The aim of this work is to show, that the
Temperate Palearctic L. trilobum can serve in the phytotherapy
analogously as the Mediterranean Palearctic T. garganica,
known for its use in the traditional medicine.
2. Experimental section
2.1. General methods
Purity of compounds determined for biological assays were
analyzed by reversed-phase HPLC as described in Section 2.7.
Structural identity of compounds was determined by the
following characteristics. Melting points were determined on
the Koffler block (Boetius)without correction. Optical rotations
were measured using the polarimeter Rudolph Research
Analytical Autopol IV. Infrared spectra were recorded on
Bruker IPS-88 instrument. NMR spectra were measured on
Bruker AVANCE 600 instrument (1H at 600.13 MHz; 13C at
150.9 MHz) in CD3OD or d6-DMSO at 300 K. Homonuclear
2D-H,H-COSY and 2D-H,H-ROESY spectra were used for
structural determination of proton signals, and heteronuclear
2D-H,C-HSQC or 2D-H,C-HMBC spectra, in combination with
13C APT spectra, were used for assigning all carbon signals.
Chemical shifts were referred to the solvent signal using
relations: δ(H) 3.31 and δ(C) 49.0 ppm in CD3OD and δ(H) 2.50
and δ(C) 39.7 ppm in d6-DMSO. Mass spectra, including
HR-MS, were recorded on LTQ Orbitrap XL (Thermo Fisher
Scientific) spectrometer.
2.2. Chemicals
The majority of sesquiterpene lactones, i.e., 1, 5–7, 9 and
10 were obtained in our earlier investigation [3]. They were
purified (see Section 2.7) from our original stored samples
and identified by MS and NMR spectroscopy. Thapsigargin
(3) was purchased from Sigma-Aldrich Company.
2.3. Plant material
Roots of L. trilobum were collected in August 1982 in the
Malá Farta mountain region, close to the village Timorádza,
Czechoslovakia (presently Slovak Republic), identified by
botanist Dr. Jan Toman [5]. A voucher specimen is deposited
in our Institute in Prague. This stored material was compared
with the presently produced plantmaterial in the experimental
station of SEVA-Flora s.r.o. in Valtice (Czech Republic) from
seeds supplied by the Botanical garden of Masaryk Universityin Brno (Czech Republic). Voucher specimens and living plants
are available in the concerned institutions. The presently used
name: Laser trilobum (L.) Borkh., is according to the Euro+Med
Plantbase of the Flora Europea known also under still
unresolved synonyms: Siler trilobum (L.) Crantz, or Laserpitium
trilobum L.
2.4. Animals and cells
Female Wistar rats weighing 175–185 g were purchased
from Velaz (Prague, CR). They were kept in transparent
plastic cages placed in an Independent Environmental Air
Flow Animal Cabinet (ESI Flufrance, Wissous, France) under
controlled 12/12 h light/dark cycle (lights on 06.00 a.m.),
temperature (22 ± 2 °C), and relative humidity (50 ± 10%)
conditions. Standard pelleted diet and water were provided
ad libitum. The animal welfare and all experimental pro-
cedures have been approved by the Institution Animal Ethics
Committee (no. 13/2006).
Rats were sacrificed by cervical dislocation. The resident
peritoneal cellswere collected by a lavage using 16 ml of sterile
saline. They were washed twice in sterile saline, and the
number of live and dead cells was counted under a microscope
using trypan blue. The suspension contained 96% of viable cells.
The flow cytometry analysis showed that the cell population
was composed of 56.5% ± 4.4% of macrophages (mean ±
SEM), 12.0% ± 3.0% of granulocytes, 10.0% ± 2.9% of lympho-
cytes and 7.1% ± 1.7% of natural killer cells. The pooled
peritoneal cells were finally re-suspended in complete culture
medium RPMI-1640, containing 10% heat-inactivated fetal
bovine serum, 2 mM L-glutamine, 50 μg/ml gentamicin, and
5 × 10−5 M 2-mercaptoethanol (all Sigma-Aldrich, St. Louis,
MO, USA). They were seeded into 96-well round-bottom
microplates (Costar, Cambridge, MA) in final 100-μl volumes,
2 × 106 cells/ml. The plates were maintained at 37 °C, 5% CO2
in a humidified Heraeus incubator. All experimental variants
were run in duplicate.
2.5. Biological assays
2.5.1. Nitric oxide assay
The cells were cultured 24 h in the presence of test
compounds. The concentration of nitrites in supernatants of
cells was taken as a measure of NO production [24]. It was
detected in individual, cell-free samples (50 μl) incubated
5 min at ambient temperature with an aliquot of a Griess re-
agent (1% sulphanilamide/0.1% (1-naphthyl)ethylenediamine/
2.5% H3PO4). The absorbance at 540 nm was recorded using a
microplate spectrophotometer (Tecan, Austria). A nitrite cali-
bration curve was used to convert absorbance to μM nitrite.
2.5.2. Cytokine assays
After an incubation period (24 h), supernatants of cellswere
analyzed for cytokine secretion. Concentrations of individual
cytokines were determined by ELISA kits (R&D Systems,
Abingdon, UK), following the manufacturer instructions.
2.5.3. Cell viability assay
Viability of cells was determined using a colorimetric assay
based on cleavage of the tetrazolium salt WST-1 by mitochon-
drial dehydrogenases in viable cells (Roche Diagnostics,
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above. After the 24-h culture, the WST-1 was added and the
cells were kept in the Heraeus incubator at 37 °C for an
additional 3 h. Optical density at 450/690 nm was evaluated.
The percentage cytotoxicity of test samples was related to the
control samples and to the samples with 100% dead cells
evoked by 1% Triton, according to the formula: [(exp. value −
control value) / (Triton value − control value)] × 100. All
control and experimental variants were run in quadruplicate.
2.5.4. Lipopolysaccharide (LPS) contamination assay
The samples were sterile filtered using non-pyrogenic
0.22 μm filters (Costar). The Limulus Amebocyte Lysate assay
(Kinetic-QCL; Cambrex Bio Science, Walkersville, MD) was
used in order to exclude possible contamination with LPS.
The samples were found to be devoid of any traces of LPS.
2.6. Statistical analysis
Analysis of variance (ANOVA) and graphical presentation of
data were done using the Prism program (GraphPad Software,
San Diego, CA).
2.7. Separation and puriﬁcation
Compounds 1, 5–7, 9 and 10 were purified by flash
chromatography on short silica gel columns using solvents:
petroleum ether–ethyl acetate (2:1), as reported in [21]. All
purified compounds were subsequently inspected by HPLC
analysis (on reverse phase Separon SGX C-18) performed in a
gradient mode with combining solvents (55–100% water in
methanol), as reported in detail in [21]. Their chemical
identity was inspected by MS and NMR spectrometry.
Trilobolide (1) was separated from stock extracts obtained
originally during the investigation reported in reference [3],
corroborating consequently the high chemical stability of the
compound. Extract (60 g) containing trilobolide (1) was
chromatographed on a column of silica gel (deactivated by
12% of water). Elution was performed with a mixture of
petroleum ether and ethyl acetate (with a gradient from 1:0 to
1:1), yielding 20 fractions combined according to the content of
identical substances (detected by TLC monitoring). From the
trilobolide containing fractions, the first portion was isolated
by crystallization (from MeOH–EtOAc), obtained in the purity
of 98%. From the mother liquors, a next batch of trilobolide by
repeated chromatography and crystallization was obtained. A
sufficiently large amount of trilobolide (11 g) was prepared by
repeating this procedure. The main portion of it was reserved
for chemical transformations, intended for the following
structure–activity relationship study [25].
The AcOEt soluble portion of the above mentioned stock
extract contained according to HPLC analysis 10 major
substances; among them the fifth one was trilobolide (1).
This portion (3.8 g) was fractionated (in two repetitions)
by preparative RP-HPLC, using column (26 × 600 mm)
packed with Separon SGX C-18, performed in gradient
mode with combination of solvents (55–100% water in
methanol) for 360 min, at a flow rate of 5 ml/min. Besides
trilobolide (1), three new sesquiterpene lactones were
obtained: 2-acetoxytrilobolide (2, 190 mg), 2-hydroxy-10-
deacetyltrilobolide (4, 12 mg) and eudeslaserolide (8,60 mg). Chemical identity of the new separated compounds,
compared with the trilobolide (1), is described below.
2.7.1. Trilobolide (1)
White crystals, m.p.190–192 °C; [α]D20 −66.3 (c 0.74 in
MeOH; the former data misquoted in [1,21] is revised). IR
(KBr) [cm−1]: 3455, 3480 (hydroxyls), 1785 (γ-lactone),
1725, 1250 (acetate), 1712 (ester conjugated with double
bond), 1652 (double bond). TOF-MS ESI+: m/z (%): 545 (100)
[M + Na]+, 485 (10), 463 (11), 385 (27), 363 (8), 261 (18),
233 (4). Composition C27H38O10 (M = 522) determined by
HR-MS: 545.23571 [M + Na], for C27H38O10Na calculated
545.23572. Full structural information based on 1H and 13C
NMR spectra is summarized in Table 1.
2.7.2. 2-Acetoxytrilobolide (2)
White powder; [α]D20 −40.8 (c 0.38 in MeOH). IR (KBr)
[cm−1]: 3456 (hydroxyls), 1780 (γ-lactone), 1726, 1235
(acetate), 1708 (ester conjugated with double bond), 1646
(double bond). TOF-MS ESI+: m/z (%): 603 (100) [M + Na]+,
519 (6), 421 (13), 399 (2), 333 (2). Composition C29H40O12
(M = 580) determined by HR-MS: 603.24123 [M + Na], for
C29H40O12Na calculated 603.24120. Full structural information
based on 1H and 13C NMR spectra is summarized in Table 1.
2.7.3. 2-Hydroxy-10-deacetyltrilobolide (4)
White powder; [α]D20 −18.0 (c 0.14 in MeOH). IR (KBr)
[cm−1]: 3462 (hydroxyls), 1776 (γ-lactone), 1730, 1236
(acetate), 1717 (ester conjugated with double bond), 1647
(double bond). TOF-MS ESI+: m/z (%): 519 (100) [M + Na]+,
447 (5), 435 (13), 408 (2), 360 (4). Composition C25H36O10
(M = 496) determined by HR-MS: 519.22001 [M + Na], for
C25H36O10Na calculated 519.22007. Full structural informa-
tion based on 1H and 13C NMR spectra is summarized in
Table 1.
2.7.4. Eudeslaserolide (8)
White powder; [α]D20 −42.9 (c 0.18 in MeOH). IR (KBr)
[cm−1]: 3434 (hydroxyls), 1776 (γ-lactone), 1737, 1244
(acetate), 1719 (ester conjugated with double bond), 1637
(double bond). TOF-MS ESI+: m/z (%): 447 (100) [M + Na]+,
387 (4), 325 (4), 265 (2), 247 (2). Composition C22H32O8
(M = 424) determined by HR-MS: 447.19883 [M + Na], for
C22H32O8Na calculated 447.19894. Full structural information
based on 1H and 13C NMR spectra is summarized in Table 1.
3. Results and discussion
3.1. Chemical identiﬁcation and structural relations
Our investigation of the immune response induced by
trilobolide (1) [16,17,21] has been extended also to other
related guaianolides 5–7 (Fig. 1) isolated either from L. trilobum
[3] or from the related species Laserpitium siler [22]. Two of
them are new guaianolides 2 and 4 (Fig. 1) added to the set of
compounds selected for the bioassay. Another new compound
is eudesmanolide 8, tested together with two previously
identified known lactones: germacranolide 9 and its
rearranged analog 10. Lactones 5–10 possess similar sub-
stituents in the same positions (C-8 and C-11), but slightly
different from the lactones 1–4, which have even more
Table 1
Proton and carbon-13 NMR data of compounds 1, 2, 4 and 8.
Proton 1
(CD3OD)
2
(CD3OD)
4
(CD3OD)
8
(d6-DMSO)
Carbon 1
(CD3OD)
2
(CD3OD)
4
(CD3OD)
8
(d6-DMSO)
1 4.42 m 4.36 m 3.46 m 3.13 dt (11.6; 5.0; 4.0) 1 52.53 58.83 63.63 77.05
2a 1.665 ddd
(14.6; 5.8; 4.8)
5.48 dd
(4.1; 2.9)
4.31 dd
(4.3; 3.4)
1.70 m
(13.6; 12.5; 11.6; 3.6)
2 33.28 85.61 78.98 26.64
2b 2.51 dt
(14.6; 8.6; 8.6)
– – 1.33 m
(12.5; 4.0; 3.6)
3 81.15 79.51 88.08 40.00
3a 5.60 m 5.665 m 5.59 m 1.51 dt
(13.6; 3.6; 3.6)
4 134.50 133.23 133.90 69.27
3b – – – 1.46 td
(13.6; 13.6; 4.0)
5 142.80 140.94 139.74 49.32
5 – – – 1.34 d
(11.3)
6 78.70 78.01 78.87 75.73
6 5.71 m 5.675 m 5.67 m 5.18 dd
(11.3; 9.2)
7 79.64 79.37 79.61 44.22
7 – – – 3.26 dd
(9.2; 4.5)
8 67.63 67.34 67.69 67.88
8 5.595 t
(3.8; 3.8)
5.59 t
(3.8; 3.7)
5.53 t
(3.8; 3.6)
5.06 dt
(6.4; 4.5; 4.1)
9 39.77 39.43 45.99 41.12
9a 2.20 dd
(14.8; 3.8)
2.28 dd
(14.6; 3.8)
1.81 dd
(14.8; 3.8)
1.63 dd
(15.1; 6.4)
10 87.00 85.87 74.06 38.84
9b 3.02 bdd
(14.8; 3.8)
2.98 ddd
(14.6; 3.7; ~0.5)
2.42 ddd
(14.8; 3.6; 0.6)
1.74 dd
(15.1; 4.1)
11 79.47 79.48 79.41 78.34
13 1.34 s 1.35 s 1.34 s 1.51 s 12 178.37 178.15 178.44 173.66
14 1.35 bs 1.41 bs 1.14 s 1.01 s 13 16.04 15.86 15.91 20.28
15 1.88 m 1.85 m 1.82 m 1.18 s 14 22.35 23.49 25.11 15.72
OAng 6.16 qq
(7.2; 1.5)
6.17 qq
(7.2; 1.5)
6.18 qq
(7.2; 1.5)
6.20 qq
(7.2; 1.5)
15 13.16 12.96 13.17 32.18
2.00 dq
(7.2; 1.5)
1.98 dq
(7.2; 1.5)
2.01 dq
(7.2; 1.5)
1.91 dq
(7.2; 1.5)
OAng 169.17 168.70 169.31 166.13
1.905 p
(1.5)
1.91 p
(1.5)
1.93 p
(1.5)
1.84 p
(1.5)
129.12 128.76 129.02 126.87
OMebu 2.33 m 2.33 m 2.32 m – 139.21 139.53 139.42 139.43
1.71 m; 1.45 m 1.70 m; 1.44 m 1.70 m; 1.44 m – 15.86 16.03 16.07 15.75
0.92 t
(7.4)
0.92 t
(7.5)
0.91 t
(7.2)
– 20.85 20.71 20.83 20.15
1.14 d
(7.2)
1.14 d
(7.0)
1.13 d
(7.0)
– OMebu 176.33 176.28 176.47 –
OAc 1.96 s 2.06 s – 1.98 s 42.71 42.66 42.74 –
1.88 s – 27.27 27.24 27.29 –
1-OH – – – 4.51 d
(5.0)
12.02 12.01 12.03 –
4-OH – – – 4.34 s 16.74 16.74 16.75 –
OAc 172.03 171.96 – 169.87
22.50 22.58 – 21.33
– 171.72 – –
– 21.07 – –
161J. Harmatha et al. / Fitoterapia 89 (2013) 157–166substituents in various other positions. Especially the addition-
al hydroxyl in position C-7, forming with the C-11 hydroxyl a
characteristic vicinal diol grouping (trans glycol) at the lactone
ring, rare among natural sesquiterpene lactones [4,23].
The identities of earlier reported major compounds:
trilobolide (1), archangelolide (5), 2-deangeloylarchangelolide
(6), acetylisomontanolide (7), laserolide (9) and isolaserolide
(10) were confirmed comparing their NMR data with the data
reported earlier [2,3,26]. The structures of new minor constit-
uents 2, 4 and 8 (Fig. 1) were elucidated by analysis of their IR,
mass, and NMR spectra (for 1H and 13C NMR data, see Table 1).
The 1H and 13C 1D spectra together with 1H, 1H–COSY and 1H,
13C–HMQC spectra were used for complete structure assign-
ment of carbon and proton signals (Table 1). Characteristic
NMR data of compounds 2 and 4 correspond with the data of
trilobolide (1) [3], thapsigargin (3) and their analogs [11,27], as
are summarized in [26].Data of the new eudeslaserolide (8) correspond with the
data of earlier reported analog lasolide from L. trilobum [3]. The
13C NMR spectrumof compound 8 in CD3OD showed 22 carbon
signals and (together with 1H NMR spectrum) allowed
determine a presence of acetate and angelate ester groups.
Four oxygen atoms of these ester groups and two oxygen
atoms of lactone group compared with formula C22H32O8
indicated that remaining oxygen atoms are probably present in
two hydroxy groups. It was confirmed by newmeasurement of
8 in DMSO, where we have observed tertiary OH group as
singlet at 4.34 ppm and secondary OH group as doublet at
4.51 ppm with J = 5.0 Hz. The detailed analysis of 2D-H,H–
COSY, 2D-H,C–HSQC and 2D-H,C–HMBC spectra allowed us to
determine the skeleton as eudesman-12,6-olide with OAc in
position 8, OAng in position 11 and OH groups in positions 1
and 4. From a biogenetic relation between compound 8 and
laserolide (9) we can expect the same relative configuration at
Fig. 2. Eudelaserolide (8) with selected observed NOE contacts (left) and vicinal J(H,H) (right).
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Fig. 3. NO production induced by lactones 1–10 at concentration
range 0.01–25.0 μM was determined after 24-h culture of rat peritoneal
cells. The test compounds are: trilobolide (1), 2-acetoxytrilobolide (2),
thapsigargin (3), 2-hydroxy-10-deacyltrilobolide (4), archangelolide (5),
2-deangeloylarchangelolide (6), acetylisomontanolide (7), eudeslaserolide (8),
laserolide (9), and isolaserolide (10). Each point is themean ± S.E.M. The data
are representative of five independent experiments (n = 3–4, each).
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vicinal J(H,H)we could determine the relative configurations in
positions 1, 4, 5, 10 and 11 in relation to those at positions 6, 7
and 8. Selected NOEs and J(H,H) in the geometry optimized
conformation of compound 8 (molecular mechanics MM2) are
shown in Fig. 2. The 1H and 13C NMR data are summarized in
Table 1. Eudeslaserolide (8) was thus identified as 4-hydroxy-
8-acetoxy derivative of lasolide or isolasolide [3].
Biogenetic relation of all test compounds, although
selected from a single plant source, is not quite apparent.
The basic skeletons of compounds 1–10 seem to be different
(belonging to four different skeletal types), nevertheless,
their biogenetic origin is effectively closely related. Their
relationship is dependent on a series of biosynthetic steps
successively assumed by various authors since early sixties,
as reviewed by Fischer et al. [23] based on a summarizing
proposal compiled by Herz [28] from many discussions going
on at that time. Thereafter, a lot of experimental evidence
(including chemical or photochemical biomimetic transfor-
mations) have been performed and published, for proving
the formerly proposed biogenetic relationships, as reported
by Adio [29]. Lactones collected from our plant source belong
really to the four biogenetically related structural types [4].
The most abundant are guaianolides (see e.g. structures 1–7)
formed by 1,5-cyclisation from the basic germacranolide type,
represented here by laserolide (9). From the same precursor it
is derived also the eudesmanolide type, represented by
eudeslaserolide (8) formed by 5,10-cyclisation, and finally
elemanolide type, represented by isolaserolide (10) shaped by
Cope rearrangement forming the 5,10-bondwith simultaneous
opening the former 2,3-bond. Structure differences of the
four basic types, increased even more by varied additional
substituents, actually indicate also a presumption of various
biological properties.
3.2. Immunobiological properties
For primary evaluation of immunobiological activities of
lactones 1–10 (0.01–25.0 μM), the effects on NO production by
rat peritoneal cells were investigated (Fig. 3). Confirming our
previous findings [16,17], the NO biosynthesis was stimulated
by trilobolide (1) and thapsigargin (3). In this paper, we
demonstrate for the first time, that also the new sesquiterpene
lactone, 2-acetoxytrilobolide (2), possesses strong ability toinduce NO production. The effects of all these compounds are
characterized by a bell-shaped dose–response curve. The most
plausible explanation of this phenomenon is the enhanced
cytotoxicity at higher concentrations of the compounds. As
described previously [16,17], both, trilobolide (1) and
thapsigargin (3) become cytotoxic at concentrations of 4–
10 μM. The same is true for 2-acetoxytrilobolide (2) (data not
shown).
On the other hand, another newly isolated and structurally
closely related 2-hydroxy-10-deacetyltrilobolide (4) as well as
other structurally related guaianolides (5–7) or biogenetically
related germacranolide-derived lactones (8–10) did not show
any immunostimulatory activity. These results indicate that
stimulation of NO production is induced by guaianolide type of
sesquiterpene lactones. The biological activity is related to the
presence of 7,11-dihydroxy-guaianolide skeleton with extend-
ed acyl substituents at positions 3 and 8, and with fixed acetyl
substituent at position 10. Similar structural conditions have
been reported for determining the appropriate pharmacophore
model resulting from the receptor mapping of the thapsigargin
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Fig. 4. Dose-dependent inhibition of NO production by lactones 5–10 in IFN-γ + LPS-stimulated rat peritoneal cells macrophages (A) and their viability in the
WST-1 assay (B) corresponding with the toxicity of archangelolide (5), 2-deangeloylarchangelolide (6), acetylisomontanolide (7), eudeslaserolide (8), laserolide
(9), and isolaserolide (10). Rat peritoneal cells 2 × 106/ml (A) and 1 × 106/ml (B) were cultured 24 h. The effects are expressed as the percent of the NO response
after stimulation with IFN-γ + LPS (A) or as the percent of untreated control (B). The points are means ± S.E.M. Data are representative of five (A) and two
(B) experiments.
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[15,30].
Sesquiterpenoids are usually described as agents with
inhibitory activity on cell functions, including NO production
[31]. Such inhibitory properties were detected (Fig. 4A) in the
group of trilobolide-related guaianolides 5–7 and in biogenet-
ically related analogs 8–10 with the −OAc substituents in
position C-8 and−OAng in position C-11.
The effect was more pronounced for laserolide (9,
IC50 = 3.3 μM), archangelolide (5, IC50 = 6.19 μM) and
2-deangeloylarchangelolide (6, IC50 = 20.87 μM), less for
isolaserolide (10, IC50 = 40.51 μM) and acetylisomontanolide
(7, IC50 = 65.66 μM), and almost none for eudeslaserolide (8,
IC50 > 100 μM), as summarized in Table 2. Compounds 5–10
possess similar ester substituents in their lactone moiety at
position C-11, but with the lactone ring anelated to 10, 7 or 6
membered rings, with their gradually decreased conformation
flexibility, directly related with the decreasing bio-activity. The
inhibitory effect of compounds onNO synthesiswas not related
to the cell viability. Using WST assay, the toxicity was not
detected in the concentration range of test compounds
(Fig. 4B).
We further examined the effect of the same representa-
tives of germacranolide, guaianolide, eudesmanolide andTable 2
Inhibition of compounds 5–10 on the NO production and cytokine secretion in the (
with 95% limits of confidence) were obtained in the assays displayed in Figs. 3–5.
Comp. NO IFN-γ
5 6.19
(4.82–7.95)
24.44
(4.55–131.2)
6 20.87
(13.49–32.28)
>100
7 65.66
(55.45–77.74)
78.50
(40.08–153.70)
8 >100 >100
9 3.30
(1,56–6.98)
4.51
(3.57–5.72)
10 40.51
(30.30–54.16)
61.41
(23.91–157.7)elemanolide lactones 5–10 on cytokine secretion (Table 2,
Fig. 5).
Highly enhanced levels of four monitored cytokines
(IFN-γ, IL-6, IL-1β and VEGF) were induced by LPS (1 μg/ml)
and the data are expressed in % of LPS response for individual
cytokine. The highest inhibitory activity was observed for
laserolide (9) with IC50 for IFN-γ, IL-6, IL-1β and VEGF: 4.5 μM,
5.2 μM, 19.3 μM and 5.4 μM, respectively. The suppression of
cytokine secretion by other lactones of guaianolide type (5–7)
and elemanolide type (10) is more pronounced for IFN-γ and
IL-6. Among these lactones, archangelolide (5) decreased IFN-γ
secretion with IC50 = 24.4 μM and IL-6 secretion with IC50 =
25.9 μM. Isoaserolide (10), which was less potent in NO
production, showed only moderate inhibitory activity IC50 =
61.4 μM and 64.7 μM for IFN-γ and IL-6, respectively. Except
laserolide (9), all trilobolide-unrelated 11-O-substituted
lactones 5–10 mildly inhibited IL-1β and VEGF secretion. A
newly identified eudeslaserolide (8), which was ineffective
to influence NO production, was also without any effect on
cytokine secretion. Taken into account differences in the
anelated ring moieties of guaianolides 5–7, eudesmanolide 8
and germacranolide 9, it is evident that inhibitory activity
is dependent on the lactone-ring anelation to the rigid
6-membered or flexible 10-memgered ringmoiety. The highestIFN-γ + LPS)-activated rat peritoneal cells. IC50 values (in μM concentrations
IL-6 IL-1β VEGF
25.89
(11.05–60.65)
>100 >100
78.54
(22.40–275.4)
>100 >100
64.42
(40.66–102.0)
>100 >100
>100 >100 >100
5.20
(3.29–8.23)
19.93
(11.83–33.57)
5.41
(2.52–11.61)
64.72
(39.83–105.2)
>100 >100
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Fig. 5. Evaluation of cytokine (IFN-γ, IL-1β, IL-6, VEGF) secretion induced by sesquiterpene lactones 5–10 in IFN-γ + LPS-stimulated rat peritoneal cells. Cells
(2 × 106/ml) were cultured in the presence of the test compounds (0.01–50.0 μM): archangelolide (5), 2-deangeloylarchangelolide (6), acetylisomontanolide
(7), eudeslaserolide (8), laserolide (9), and isolaserolide (10). Incubation period was 24 h. Cytokines were assayed using ELISA. The data are means ± S.E.M.
representing one of two identical experiments.
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laserolide (9), which is effective at IC50 of approximately 5 μM.
It also inhibits VEGF, a factor known to be associated with
the tumor growth. In contrast to many other sesquiterpene
lactones, laserolide (9) is free of cytocidal effects up to a
concentration of 50 μM. This compound appears to be a
promising candidate for further research [32].
The stimulatory effect of well-known thapsigargin (3) and
structurally related trilobolides (1, 2 and 4) on NO produc-
tion leads us to hypothesize that these compounds are potent
stimulators of cytokines, especially IFN-γ. Recently we docu-
mented [16,17] that thapsigargin (3) and trilobolide (1) are
potent stimulators of IFN-γ secretion in a range of low
concentrations (10 nM–10 μM). Here (see Fig. 6), we report
for the first time a substantial stimulation of IFN-γ secretion
induced by newly isolated 2-acetoxytrilobolide (2). The IFN-γ
secretion in the presence of compound 2 (at 1 μM and 4 μM)
reached the levels triggered by compounds 1 and 3. On the
other hand, another structurally transformed 2-hydroxy-10-
deacetyltrilobolide (4) did not show any activity.
We have revealed the significant induction of IFN-γ
production by several specific guaianolides (Fig. 6). This is a
unique property among natural compounds. Nevertheless, it
may be presumed that this stimulatory activity is accompa-
nied by secretion of other cytokines. We further investigatedsecretion of IL-1β and IL-6 cytokines, VEGF and GM-CFS.
We observed that thapsigargin (3), trilobolide (1) and
2-acetoxytrilobolide (2) stimulated production of these
cytokines. In sharp contrast with the immunostimulatory
activity of those three trilobolide-related derivatives was the
2-hydroxy-10-deacetyltrilobolide (4). The results did not show
cytokine production of the compound 4. We can conclude, that
beyond the 7,11-diol formation, ester substituents in positions
C-2 and C-10 (or none in the C-2 of the trilobolide (1)) are
important for immunostimulatory activity, i.e. cytokine secre-
tion and NO synthesis (see Fig. 3). If they are replaced by
hydroxyl groups (as it is in the compound 4), the ability to
secrete cytokines was completely lost.Acknowledgments
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